Used primarily in pharmaceutical research as a key intermediate in the synthesis of tropane alkaloid derivatives. These compounds are important in the development of central nervous system agents, particularly those targeting neurotransmitter receptors such as dopamine, serotonin, and acetylcholine. The structure supports the creation of bioactive molecules with potential applications in treating neurological disorders, including depression, schizophrenia, and Parkinson’s disease. It is also employed in the preparation of selective receptor ligands for use in neuropharmacology studies. Due to its rigid bicyclic framework, it enhances binding specificity and metabolic stability in drug candidates.